VCM
JNJ icon

Versant Capital Management’s Johnson & Johnson JNJ Stock Holding History

Versant Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.51M Sell
13,834
-664
-5% -$155K 0.32% 51
2026
Q1 		$3.54M Buy
14,498
+2,921
+25% +$680K 0.35% 43
2025
Q4 		$2.4M Sell
11,577
-298
-3% -$58.9K 0.3% 49
2025
Q3 		$2.2M Buy
11,875
+1,272
+12% +$218K 0.3% 49
2025
Q2 		$1.62M Buy
10,603
+2,178
+26% +$335K 0.25% 55
2025
Q1 		$1.4M Buy
8,425
+3,747
+80% +$586K 0.23% 60
2024
Q4 		$677K Buy
4,678
+1,019
+28% +$158K 0.15% 80
2024
Q3 		$593K Buy
3,659
+332
+10% +$52.9K 0.14% 78
2024
Q2 		$486K Buy
3,327
+1,132
+52% +$168K 0.12% 78
2024
Q1 		$347K Sell
2,195
-261
-11% -$41.5K 0.1% 85
2023
Q4 		$385K Sell
2,456
-31
-1% -$4.75K 0.11% 82
2023
Q3 		$387K Sell
2,487
-97
-4% -$16K 0.12% 83
2023
Q2 		$428K Buy
2,584
+26
+1% +$4.2K 0.14% 78
2023
Q1 		$396K Buy
2,558
+199
+8% +$32.1K 0.13% 76
2022
Q4 		$417K Sell
2,359
-196
-8% -$33.8K 0.15% 65
2022
Q3 		$417K Sell
2,555
-3
-0.1% -$508 0.16% 69
2022
Q2 		$454K Buy
2,558
+79
+3% +$14.1K 0.17% 67
2022
Q1 		$439K Sell
2,479
-305
-11% -$51.9K 0.14% 75
2021
Q4 		$476K Sell
2,784
-14
-0.5% -$2.29K 0.16% 72
2021
Q3 		$452K Sell
2,798
-20
-0.7% -$3.41K 0.16% 62
2021
Q2 		$464K Sell
2,818
-490
-15% -$81.1K 0.17% 67
2021
Q1 		$544K Buy
3,308
+4
+0.1% +$647 0.2% 59
2020
Q4 		$520K Sell
3,304
-955
-22% -$141K 0.21% 58
2020
Q3 		$634K Sell
4,259
-29
-0.7% -$4.29K 0.28% 44
2020
Q2 		$603K Sell
4,288
-15
-0.3% -$2.19K 0.28% 43
2020
Q1 		$564K Buy
4,303
+420
+11% +$59.6K 0.3% 41
2019
Q4 		$566K Sell
3,883
-193
-5% -$26.2K 0.29% 46
2019
Q3 		$527K Sell
4,076
-8
-0.2% -$1.05K 0.25% 50
2019
Q2 		$568K Sell
4,084
-670
-14% -$92.7K 0.26% 50
2019
Q1 		$664K Sell
4,754
-71
-1% -$9.51K 0.28% 40
2018
Q4 		$622K Buy
4,825
+34
+0.7% +$4.74K 0.29% 41
2018
Q3 		$662K Sell
4,791
-192
-4% -$25.5K 0.27% 40
2018
Q2 		$604K Sell
4,983
-167
-3% -$20.8K 0.25% 42
2018
Q1 		$660K Sell
5,150
-216
-4% -$29.2K 0.27% 45
2017
Q4 		$749K Buy
5,366
+341
+7% +$47.5K 0.3% 45
2017
Q3 		$653K Sell
5,025
-106
-2% -$14.1K 0.36% 31
2017
Q2 		$678K Sell
5,131
-291
-5% -$37.1K 0.37% 32
2017
Q1 		$675K Buy
5,422
+72
+1% +$8.6K 0.37% 31
2016
Q4 		$616K Buy
5,350
+133
+3% +$15.4K 0.35% 35
2016
Q3 		$616K Sell
5,217
-78
-1% -$9.46K 0.35% 32
2016
Q2 		$642K Sell
5,295
-6
-0.1% -$682 0.38% 33
2016
Q1 		$573K Buy
5,301
+99
+2% +$10.3K 0.35% 35
2015
Q4 		$534K Buy
+5,202
New +$523K 0.33% 31

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Versant Capital Management's JNJ Position: Q2 2026 in Review

Versant Capital Management reduced its Johnson & Johnson (JNJ) stake by 4.6% in Q2 2026, selling an estimated $155K and leaving 13,834 shares worth $3.51M. The position accounts for 0.32% of the portfolio, ranked #51.

Versant Capital Management first reported a position in JNJ in Q4 2015 and has held it in 43 quarters since. The position peaked at $3.54M in Q1 2026. 1,422 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Versant Capital Management held 13,834 shares of Johnson & Johnson worth $3.51M as of Q2 2026.
  • Versant Capital Management sold 664 Johnson & Johnson shares in Q2 2026, an estimated $155K.
  • Johnson & Johnson made up 0.32% of Versant Capital Management's portfolio in Q2 2026, its #51 holding.
  • Versant Capital Management first reported a position in Johnson & Johnson in Q4 2015 and has held it in 43 quarters since.
  • Versant Capital Management's Johnson & Johnson position peaked at $3.54M in Q1 2026.
  • 1,422 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.